IRIS
ZULIANI, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.429
EU - Europa 1.410
AS - Asia 501
SA - Sud America 4
Totale 3.344
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.406
CN - Cina 439
FI - Finlandia 335
SE - Svezia 278
IE - Irlanda 260
UA - Ucraina 193
DE - Germania 122
IT - Italia 118
GB - Regno Unito 43
TR - Turchia 41
CA - Canada 23
BE - Belgio 15
AT - Austria 14
IN - India 12
CZ - Repubblica Ceca 10
SG - Singapore 7
PT - Portogallo 6
FR - Francia 4
CL - Cile 3
NL - Olanda 3
IR - Iran 2
RU - Federazione Russa 2
BG - Bulgaria 1
BR - Brasile 1
EE - Estonia 1
ES - Italia 1
LI - Liechtenstein 1
LT - Lituania 1
RO - Romania 1
RS - Serbia 1
Totale 3.344
Salva come PNG Salva come JPEG
Città #
Chandler 279
Dublin 260
Jacksonville 214
Ann Arbor 119
Beijing 106
Dearborn 101
Nanjing 81
Ashburn 80
Princeton 51
Izmir 41
San Mateo 40
New York 36
Wilmington 35
Parma 32
Shanghai 29
Bremen 25
Hebei 23
Los Angeles 23
Milan 23
Shenyang 23
Nanchang 22
Helsinki 21
Toronto 21
Boardman 20
Jinan 20
Kunming 19
Hefei 16
Brussels 15
Vienna 14
Des Moines 13
Seattle 13
Guangzhou 12
Jiaxing 12
Woodbridge 12
Auburn Hills 7
Changsha 7
Norwalk 7
Pune 7
Tianjin 7
Piacenza 6
Brno 5
Chengdu 5
Haikou 5
Reggio Nell'emilia 5
Abbiategrasso 4
Brescia 4
Falls Church 4
Roncadelle 4
Taiyuan 4
Augusta 3
Borås 3
Buccinasco 3
Castelo Branco 3
Düsseldorf 3
Grafing 3
Gualtieri 3
Hangzhou 3
Houston 3
Modena 3
St Andrews 3
Taizhou 3
Xian 3
Zhengzhou 3
Castelcovati 2
Cesena 2
Chongqing 2
Fairfield 2
Fuzhou 2
Lanzhou 2
Miami 2
Montepulciano 2
Naples 2
Oakville 2
Quzhou 2
Wuhan 2
Ardabil 1
Atlanta 1
Baotou 1
Brooklyn 1
Changchun 1
Changle 1
Charlotte 1
Chicago 1
Frankfurt am Main 1
Grezzago 1
Huizen 1
London 1
Madrid 1
Massa 1
Niles 1
Ningbo 1
Norwich 1
Phoenix 1
Redwood City 1
Santa Vittoria 1
Schaan 1
Sofia 1
Southend 1
Stockholm 1
Tallinn 1
Totale 2.023
Salva come PNG Salva come JPEG
Nome #
2-Aminobenzimidazoles as new potent H3-antagonists 110
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 92
Synthesis and 3D-QSAR Analysis of H3 Receptor Antagonists Containing a Neutral Heterocyclic Polar Group 90
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 88
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 87
5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity 85
Aminobenzimidazoles as new potent H3-antagonists 84
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 83
Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups 83
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 81
Meccanismo d’azione di UPR 1024: un nuovo farmaco con attività antiproliferativa in cellule di carcinoma polmonare umano 78
Antiproliferative and proapototic effects of a new combi-molecule on non small cell lung cancer cell lines 78
CNS access of selected H3-antagonists: ex vivo binding study in rats 77
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 76
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line 74
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 72
Novel Sodium Channel Antagonists in the Treatment of Neuropathic Pain 71
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 71
Chiral NMR discrimination of the diastereoisomeric salts of the H(3)-antagonist 2-[3-(1H-imidazol-4-ylmethyl)piperidin-1-yl]-1H-benzimidazole. 70
Development of a GPCR model for SAR interpretation of classical and new H3 antagonists 70
Drug repurposing approaches to fight Dengue virus infection and related diseases 69
A Short and Efficient Synthesis of the Selective H4 Receptor Agonist 4-Methylhistamine 68
Dual mechanisms of action of the 5-benzylidene-hydantoin UPR1024 on lung cancer cell lines 68
5-benzylidene-hydantoin UPR 1024 acts as EGFR inhibitor and induces DNA damage in A549 NSCLC cell line 68
Advances in Design and Development of Sodium Channel Blockers. 67
Structure-Property Relationships on Histamine H3-Antagonists: Binding of Phenyl-substituted Alkylthioimidazole Derivatives to Rat Plasma Proteins 66
2,4(5)-Diarylimidazoles: Synthesis and Biological Evaluation of a New Class of Sodium Channel Blockers against hNav1.2 65
5-benzylidene-hydantoins as new inhibitors of cell proliferation 65
Imidazole H3-antagonists: Relationship between Structure and Ex-vivo binding to Rat Brain H3-Receptors 65
Relationship between structure and ex-vivo binding of imidazole H3 antagonists to rat brain H3 receptors 64
NMR Analysis of a Series of Imidazobenzoxazines 61
Three-Dimensional Quantitative Structure-Activity Relationship Studies on Selected MT1 and MT2 Melatonin Receptor Ligands: Requirements for Subtype Selectivity and Intrinsic Activity Modulation 61
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 61
Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry 59
Histamine H3-antagonists: the basicity of the polar group in quantitative structure-activity and structure-property relationship 58
Sodium Channel Blocking Activity and In-vivo Testing of New Phenyl-imidazole Derivatives. 56
Anticonvulsant Activity of 2,4(5)-Diarylimidazoles in Mice and Rat Models 54
2,4(5)-Diarylimidazoles as Inhibitors of hNaV1.2 Sodium Channels: Pharmacological Evaluationand Structure-Property Relationships 53
Biological evaluation of imidazobenzoxazines, imidazobenzoxazin-5-ones and imidazobenzoxazin-5-thiones as sodium channel blockers 53
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 51
Sodium channel blockers: a patent review (2010 - 2014) 51
Anticonvulsant Activity of 2,4(1H)-Diarylimidazoles in Mice and Rats Acute Seizure Models 49
Sodium Channel Blockers as Therapeutic Target for Treating Epilepsy: Recent Updates 49
A Practical Synthesis of 2,4(5)-Diarylimidazoles from Simple Building Blocks 48
Recent Advances in the Medicinal Chemistry of Sodium Channel Blockers and their Therapeutic Potential 46
In vivo Screening of Diarylimidazoles as Anticonvulsant Agents 46
Sodium channel blockers for neuropathic pain. 42
Fluorescent Ligands for the Histamine H2 Receptor: Synthesis and Preliminary Characterization 41
Microwave Assisted Efficient Synthesis of Imidazole-based Privileged Structure 40
null 36
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 32
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses 25
pH-partition profiles of 4-(3-oxo-1,2-benzisothiazolin-2-yl)phenyl and phenoxyalkanoic acids 24
Erratum: Fluorescent ligands for the histamine H 2 receptor: Synthesis and preliminary characterization (Bioorganic & Medicinal Chemistry (2004) 12 (6495-6503)) 20
Totale 3.401
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.248
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.248
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201961 0 0 0 0 0 0 0 0 0 0 60 1
2019/2020757 110 117 46 12 66 73 102 18 72 64 22 55
2020/2021374 6 52 35 12 43 6 54 11 73 16 61 5
2021/2022251 2 5 6 20 11 8 33 35 15 18 27 71
2022/20231.103 119 120 83 76 101 143 19 46 322 16 40 18
2023/2024317 14 41 13 11 39 96 40 23 17 23 0 0
Totale 3.401